During the past decade, Cardiovascular Research of Northwest Indiana conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cardiovascular Research of Northwest Indiana" #1 sponsor was "Abbott Medical Devices" with 1 trials, followed by "Angiodynamics, Inc." with 1 trials sponsored, "Duke University" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Idorsia Pharmaceuticals Ltd." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiovascular Research of Northwest Indiana" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Janssen Biotech, Inc." with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Cardiovascular Research of Northwest Indiana" are "Acute Kidney Injury" (1 trials), "Acute Renal Failure" (1 trials), "Atrial Fibrillation" (1 trials), "Cardiac Arrhythmia" (1 trials) and "Chronic Kidney Disease" (1 trials). Many other conditions were trialed in "Cardiovascular Research of Northwest Indiana" in a lesser frequency.

Most popular intervention types in "Cardiovascular Research of Northwest Indiana" are "Device" (3 trials), "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Aprocitentan 12.5 mg" (1 trials), "Aprocitentan 25 mg" (1 trials), "Arrhythmia Management System (AMS)" (1 trials) and "Benephit catheter for Targeted Renal Therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiovascular Research of Northwest Indiana" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Cardiovascular Research of Northwest Indiana". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Cardiovascular Research of Northwest Indiana, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cardiovascular Research of Northwest Indiana, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".